Skip to main navigation menu Skip to main content Skip to site footer

Viewpoint

Vol. 151 No. 5152 (2021)

Development of a value-based healthcare delivery model for sarcoma patients 

  • Bruno Fuchs
  • Gabriela Studer
  • Beata Bode
  • Hanna Wellauer
  • Annika Frei
  • Carlo Theus
  • Guido Schüpfer
  • Jan Plock
  • Hubi Windegger
  • Stefan Breitenstein
DOI
https://doi.org/10.4414/SMW.2021.w30047
Cite this as:
Swiss Med Wkly. 2021;151:w30047
Published
24.12.2021

Summary

The urgent need to restructure healthcare delivery to address rising costs has been recognised. Value-based health care aims to deliver high and rising value for the patient by addressing unmet needs and controlling costs. Sarcoma is a rare disease and its care is therefore usually not organised as an institutional discipline. It comprises a set of various diagnostic entities and is highly transdisciplinary. A bottom-up approach to establishing sarcoma integrated practice units (IPUs) faces many challenges, but ultimately allows the scaling up of quality and outcomes of patient care, specific knowledge, experience and education. The key for value-based health care – besides defining the shared value of quality – is an integrated information technology platform that allows transparency by sharing values, brings all stakeholders together in real-time,  and offers the opportunity to assess quality of care and outcomes, thereby ultimately saving costs. Sarcoma as a rare disease may serve as a  model of how to establish IPUs through a supraregional network by increased connectivity, to advance patient care, to improve science and education, and to control costs in the future, thereby restructuring healthcare delivery. This article describes how the value-based health care delivery principles are being adopted and fine-tuned to the care of sarcoma patients, and already partially integrated in seven major referral hospitals in Switzerland.

References

  1. Hartman M, Martin AB, Espinosa N, Catlin A ; The National Health Expenditure Accounts Team. National Health Care Spending In 2016: Spending And Enrollment Growth Slow After Initial Coverage Expansions. Health Aff (Millwood). 2018 Jan;37(1):150–60. https://doi.org/10.1377/hlthaff.2017.1299
  2. Scholer M. Wenn wir so weitermachen, fahren wir das System an die Wand. Schweiz Arzteztg. 2017;98(15-16):495-7.
  3. Noseworthy J. Why Mayo Clinic, despite its five-star rating, believes it’s time to rethink how quality is graded. Mod Healthc. 2016 Oct;46(43):29.
  4. Porter ME, Teisberg EO. Redefining competition in health care. Harv Bus Rev. 2004 Jun;82(6):64–76.
  5. Porter ME, Pabo EA, Lee TH. Redesigning primary care: a strategic vision to improve value by organizing around patients’ needs. Health Aff (Millwood). 2013 Mar;32(3):516–25. https://doi.org/10.1377/hlthaff.2012.0961
  6. Porter ME. A strategy for health care reform—toward a value-based system. N Engl J Med. 2009 Jul;361(2):109–12. https://doi.org/10.1056/NEJMp0904131
  7. Porter ME, Lee TH. From Volume to Value in Health Care: The Work Begins. JAMA. 2016 Sep;316(10):1047–8. https://doi.org/10.1001/jama.2016.11698
  8. Porter ME. Value-based health care delivery. Ann Surg. 2008 Oct;248(4):503–9. https://doi.org/10.1097/SLA.0b013e31818a43af
  9. Lin CC, Smeltzer MP, Jemal A, Osarogiagbon RU. Risk-Adjusted Margin Positivity Rate as a Surgical Quality Metric for Non-Small Cell Lung Cancer. Ann Thorac Surg. 2017 Oct;104(4):1161–70. https://doi.org/10.1016/j.athoracsur.2017.04.033
  10. Lazarides AL, Kerr DL, Nussbaum DP, Kreulen RT, Somarelli JA, Blazer DG 3rd, et al. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers? Clin Orthop Relat Res. 2019 Apr;477(4):718–27. https://doi.org/10.1097/01.blo.0000533623.60399.1b
  11. Osarogiagbon RU. Volume-Based Care Regionalization: pitfalls and Challenges. J Clin Oncol. 2020 Oct;38(30):3465–7. https://doi.org/10.1200/JCO.20.02269
  12. Swensen SJ, Dilling JA, Harper CM Jr, Noseworthy JH. The Mayo Clinic Value Creation System. Am J Med Qual. 2012 Jan-Feb;27(1):58–65. https://doi.org/10.1177/1062860611410966
  13. Porter ME, Lee TH. Integrated Practice Units: A Playbook for Health Care Leaders. NEJM Catal. 2021;2(1):CAT.20.0237. https://doi.org/10.1056/CAT.20.0237
  14. Porter ME, Lee TH, Murray AC. The Value-Based Geography Model of Care. NEJM Catal. 2020;1(2):CAT.19.1130. https://doi.org/10.1056/CAT.19.1130
  15. Noseworthy J. The Future of Care - Preserving the Patient-Physician Relationship. N Engl J Med. 2019 Dec;381(23):2265–9. https://doi.org/10.1056/NEJMsr1912662
  16. Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, et al. ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review. Crit Rev Oncol Hematol. 2017 Feb;110:94–105. https://doi.org/10.1016/j.critrevonc.2016.12.002
  17. Blay JY, Soibinet P, Penel N, Bompas E, Duffaud F, Stoeckle E, et al. Improved survival using specialized multidisciplinary board in sarcoma patients. Ann Oncol. 2017 Nov;28(11):2852–9. https://doi.org/10.1093/annonc/mdx484

Most read articles by the same author(s)